Debate contribution: ADHD Medication: Shortages

Debate contribution by Mr Robin Swann on .

MLA
Mr Robin Swann
Party at the time
Ulster Unionist Party
Date
21 May 2024
Type
Debate contribution
Business
Oral Answers to Questions
Heading
ADHD Medication: Shortages
Assembly identifier
Official Report component 4491700

Text

I thank the Member for her point. Whilst supply disruptions of some ADHD treatments have now been resolved, my Department is, like her, aware of ongoing supply disruptions that involve various strengths and preparations of other ADHD treatments across the UK, caused by a combination of manufacturing issues and the increase in global demand for such products. As the Department of Health and Social Care (DHSC) leads on the maintenance of medicine supply chains to the UK, my Department has been working closely with it, other devolved Governments and the MHRA to ensure that the impacts of the shortages are mitigated and that patients continue to get the medical supplies that they need. Nationally and locally tried-and-tested mitigations are in place to deal with medicine shortages. During the period of supply disruption of medicines and treatments, communications were issued to healthcare professionals across Health and Social Care settings that provided advice on the appropriate actions to take to manage patients affected by the disruption. It is anticipated that issues currently affecting ADHD treatment will be resolved at various dates between this month and September.

184 words. Text as published by the Northern Ireland Assembly.

Assessment

Awaiting analysis

This record has not been analysed yet. It is not counted in any total until it has been assessed.

Disagree with this assessment?

Classifications can be challenged. A person reviews every challenge, and any change is recorded publicly above with its reason.

Challenge this classification